New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

by Tokyo Metropolitan University(top) Intracellular localization of RUNX2 and YAP in MSCs on gelatin gels with different elastic moduli. Notice how more signal is seen in a single location (the nucleu
World medicine November 30,2023
Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

by Tokyo Metropolitan University(top) Intracellular localization of RUNX2 and YAP in MSCs on gelatin gels with different elastic moduli. Notice how more signal is seen in a single location (the nucleu
World medicine November 30,2023
The start of a new era in stem cell therapy

The start of a new era in stem cell therapy

byKoc UniversityCredit: Koc UniversityA recent study published in the April 8 issue ofNature Chemical Biologyimproves on the "Cellular Reprogramming" method developed by No
World medicine November 30,2023
The start of a new era in stem cell therapy

The start of a new era in stem cell therapy

byKoc UniversityCredit: Koc UniversityA recent study published in the April 8 issue ofNature Chemical Biologyimproves on the "Cellular Reprogramming" method developed by No
World medicine November 30,2023
Combining potent cancer drugs in a single multitargeting molecule

Combining potent cancer drugs in a single multitargeting molecule

byWileyCredit: PtIVprodrug (2) can release Gem, Oxal, and Dox in their active form upon cellular reduction. It effectively induces release of ICD markers, DAMPs (CALR, ATP & HMGB1) in
World medicine November 30,2023
Combining potent cancer drugs in a single multitargeting molecule

Combining potent cancer drugs in a single multitargeting molecule

byWileyCredit: PtIVprodrug (2) can release Gem, Oxal, and Dox in their active form upon cellular reduction. It effectively induces release of ICD markers, DAMPs (CALR, ATP & HMGB1) in
World medicine November 30,2023
Stem cells moonlight to protect the stomach from bacterial invaders

Stem cells moonlight to protect the stomach from bacterial invaders

byMax Planck SocietyCross-section through the gastric mucosa of a mouse: Helicobacter pylori bacteria (green) colonize the cavities of the gastric glands. The nuclei of the mucous membrane cells
World medicine November 30,2023
Stem cells moonlight to protect the stomach from bacterial invaders

Stem cells moonlight to protect the stomach from bacterial invaders

byMax Planck SocietyCross-section through the gastric mucosa of a mouse: Helicobacter pylori bacteria (green) colonize the cavities of the gastric glands. The nuclei of the mucous membrane cells
World medicine November 30,2023
Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

byPublic Library of ScienceHow chemotherapy awakens dormant cancer cells (on the left) resulting in tumor outgrowth (on the right). Credit:PLoS Biology(2023). DOI: 10.1371/journal.pb
World medicine November 30,2023
Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

byPublic Library of ScienceHow chemotherapy awakens dormant cancer cells (on the left) resulting in tumor outgrowth (on the right). Credit:PLoS Biology(2023). DOI: 10.1371/journal.pb
World medicine November 30,2023
Stem cell researchers reactivate 'back-up genes' in the lab

Stem cell researchers reactivate 'back-up genes' in the lab

byKU LeuvenMost female mammals have two X chromosomes, but only one of these is active in any given cell. In the images above, the yellow arrows point to the inactive X chromosome. DNA is shown
World medicine November 30,2023
Stem cell researchers reactivate 'back-up genes' in the lab

Stem cell researchers reactivate 'back-up genes' in the lab

byKU LeuvenMost female mammals have two X chromosomes, but only one of these is active in any given cell. In the images above, the yellow arrows point to the inactive X chromosome. DNA is shown
World medicine November 30,2023
Stem cells provide hope for dwindling wildlife populations

Stem cells provide hope for dwindling wildlife populations

byZoological Society of San DiegoCredit: CC0 Public DomainA paper recently published in the scientific journalStem Cells and Developmentshares an important advancement in conservatio
World medicine November 30,2023
Stem cells provide hope for dwindling wildlife populations

Stem cells provide hope for dwindling wildlife populations

byZoological Society of San DiegoCredit: CC0 Public DomainA paper recently published in the scientific journalStem Cells and Developmentshares an important advancement in conservatio
World medicine November 30,2023
AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

by Eric Horvath,Perelman School of Medicine at the University of PennsylvaniaCell type and lack of substructure association of vector DNA and RNA following i.v. administration of AAV vectors to
World medicine November 30,2023
AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

by Eric Horvath,Perelman School of Medicine at the University of PennsylvaniaCell type and lack of substructure association of vector DNA and RNA following i.v. administration of AAV vectors to
World medicine November 30,2023
Stem cells regulate their fate by altering their stiffness

Stem cells regulate their fate by altering their stiffness

byAlbert Ludwigs University of FreiburgImmunofluorescence staining of matrix proteins in engineered cartilage. Credit: Institut für Makromolekulare ChemieIn adults, mesenchymal stems cells (MSCs
World medicine November 30,2023
Stem cells regulate their fate by altering their stiffness

Stem cells regulate their fate by altering their stiffness

byAlbert Ludwigs University of FreiburgImmunofluorescence staining of matrix proteins in engineered cartilage. Credit: Institut für Makromolekulare ChemieIn adults, mesenchymal stems cells (MSCs
World medicine November 30,2023
Study finds higher than expected risk of cancer following 'all clear' after suspected cancer referral

Study finds higher than expected risk of cancer following 'all clear' after suspected cancer referral

byQueen Mary, University of LondonCredit: Karolina Grabowska from PexelsA new study led by Queen Mary University of London finds that people who were referred to urgent suspected cancer pathways
World medicine November 30,2023
Study finds higher than expected risk of cancer following 'all clear' after suspected cancer referral

Study finds higher than expected risk of cancer following 'all clear' after suspected cancer referral

byQueen Mary, University of LondonCredit: Karolina Grabowska from PexelsA new study led by Queen Mary University of London finds that people who were referred to urgent suspected cancer pathways
World medicine November 30,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com